Dr Reddy's launches generic Revlimid in US market

"We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity. Bringing a more affordable generic version to market creates greater patient access for this important drug," Marc Kikuchi, CEO, North America Generics, Dr. Reddy's said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news